Table VI.
Adverse events | Patients receiving MET (n=52) | Patients not receiving MET (n=26) | P-value |
---|---|---|---|
Any grade, n (%) | 19 (36.5) | 16 (61.5) | 0.0376 |
Grade 3/4, n (%) | 10 (19.2) | 11 (42.4) | 0.0314 |
Leukopenia | 7 | 5 | |
Cystitis | 1a | – | |
Febrile neutropenia | 1 | – | |
Thrombocytopenia | 1a | – | |
Hand-foot syndrome | – | 1 | |
Heart failure | – | 1a | |
Neuropathy | – | 1a | |
Pneumonia | – | 1a | |
Proteinuria | – | 1 | |
Anorexia | – | 1a |
Leading to treatment discontinuation. Bold print indicates statistical significance. MET, metronomic chemotherapy.